PARENTERAL RIFAMPICIN IN TUBERCULOUS AND SEVERE NON-MYCOBACTERIAL INFECTIONS - CLINICAL-DATA ON 237 PATIENTS

被引：5

作者：

KISSLING, M

BERGAMINI, N

XILINAS, M

机构：

来源：

CHEMOTHERAPY | 1982年 / 28卷 / 03期

关键词：

D O I：

10.1159/000238082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：229 / 239

页数：11

共 32 条

[21] SUPPRESSION OF APPEARANCE OF BACTERIAL MUTANTS BY COMBINED ANTIBACTERIAL THERAPY [J].

LACEY, RW .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (05) :391-392

[22] SUSCEPTIBILITY OF PATHOGENIC ACTINOMYCETES TO ANTIMICROBIAL COMPOUNDS [J].

LERNER, PI .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 5 (03) :302-309

[23]

LUBOSHITZKI R, 1975, CHEMOTHERAPY, V19, P354

[24] KILLING OF INTRALEUKOCYTIC STAPHYLOCOCCUS-AUREUS BY RIFAMPIN - IN-VITRO AND IN-VIVO STUDIES [J].

MANDELL, GL ;

VEST, TK .

JOURNAL OF INFECTIOUS DISEASES, 1972, 125 (05) :486-&

[25]

MEYERROHN J, 1969, 6TH P INT C CHEM TOK, V1, P330

[26]

NICOUCAR R, 1969, 1968 S RIM CIBA BAS, P59

[27] EVALUATION OF DIFFERENT ANTIBIOTIC ACTIONS COMBINED WITH RIFAMPICIN - INVITRO SYNERGISM AGAINST PSEUDOMONAS AND PROTEUS [J].

PEREZURENA, MT ;

BARASOAIN, I ;

ESPINOSA, M ;

GARCIA, E ;

PORTOLES, A .

CHEMOTHERAPY, 1975, 21 (02) :82-89

[28]

ROLLAG H JR, 1975, Meddelelser fra Norsk Farmaceutisk Selskap, V37, P123

[29]

SAMSON J, 1977, COLLECT ANN I PAST C, V128, P75

[30]

SHANSON D C, 1976, Journal of Antimicrobial Chemotherapy, V2, P81, DOI 10.1093/jac/2.1.81

← 1 2 3 4 →